RNAi modulation of ApoB and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9187747
APP PUB NO 20140045922A1
SERIAL NO

14058679

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to compositions and methods for modulating the expression of apolipoprotein B, and more particularly to the downregulation of apolipoprotein B by chemically modified oligonucleotides.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALNYLAM PHARMACEUTICALS INC300 THIRD STREET 3RD FLOOR CAMBRIDGE MA 02142-1110

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Elbashir, Sayda Cambridge, US 13 223
Hadwiger, Philipp Altenkunstadt, DE 66 2667
Soutschek, Juergen Kasendorf, DE 14 62
Vornlocher, Hans-Peter Bayreuth, DE 97 2123

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 17, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00